Sumitomo Pharma Co Ltd
TSE:4506
Sumitomo Pharma Co Ltd
Operating Expenses
Sumitomo Pharma Co Ltd
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sumitomo Pharma Co Ltd
TSE:4506
|
Operating Expenses
-¥392.8B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-5%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Operating Expenses
-¥2.6T
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-9%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Operating Expenses
-¥974.8B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Operating Expenses
-¥1.2T
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Operating Expenses
-¥259.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-5%
|
|
Astellas Pharma Inc
TSE:4503
|
Operating Expenses
-¥1.3T
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-8%
|
See Also
What is Sumitomo Pharma Co Ltd's Operating Expenses?
Operating Expenses
-392.8B
JPY
Based on the financial report for Dec 31, 2023, Sumitomo Pharma Co Ltd's Operating Expenses amounts to -392.8B JPY.
What is Sumitomo Pharma Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-5%
Over the last year, the Operating Expenses growth was -6%. The average annual Operating Expenses growth rates for Sumitomo Pharma Co Ltd have been -11% over the past three years , -7% over the past five years , and -5% over the past ten years .